A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers
NCT06013163
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Overweight or Obesity
Interventions
DRUG:
Xenical® vs EMP 22
DRUG:
EMP 22 vs Xenical®
DRUG:
EMP 16 vs Xenical®
Sponsor
Empros Pharma AB
Collaborators
[object Object]